## **Core Concept**
Anti-glomerular basement membrane (anti-GBM) antibodies are a type of autoantibody that targets the glomerular basement membrane. These antibodies are primarily associated with autoimmune disorders affecting the kidneys and lungs. The presence of anti-GBM antibodies is a hallmark for the diagnosis of certain conditions.

## **Why the Correct Answer is Right**
The correct answer, Goodpasture's syndrome, is a rare autoimmune disorder characterized by the presence of anti-GBM antibodies. These antibodies specifically target the type IV collagen in the glomerular and alveolar basement membranes, leading to glomerulonephritis and pulmonary hemorrhage. The mechanism involves the binding of anti-GBM antibodies to the basement membrane, triggering an inflammatory response and damage to the affected tissues.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While anti-GBM antibodies can cause kidney damage, the term "minimal change disease" refers to a condition characterized by nephrotic syndrome with minimal changes on light microscopy. It is not typically associated with anti-GBM antibodies.
- **Option B:** "Membranous nephropathy" is another type of kidney disease that involves changes to the glomerular basement membrane but is more commonly associated with immune complex deposition rather than anti-GBM antibodies.
- **Option C:** This option is not provided, so we proceed with the understanding that Goodpasture's syndrome is the correct association.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that Goodpasture's syndrome often presents with a combination of renal and pulmonary symptoms, such as hematuria, proteinuria, and cough or hemoptysis. Rapid diagnosis and treatment are critical to prevent severe organ damage. The presence of anti-GBM antibodies is diagnostic, and treatment typically involves immunosuppression and plasmapheresis.

## **Correct Answer:** D. Goodpasture's syndrome.